Schedule of Warrant Activity (Details) - Warrant [Member] - $ / shares |
3 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||
| Number of Warrants, Balance | 3,090,042 | 314,194 | 105,557 | 56,941 | 56,941 | |
| Weighted Average Exercise Price, Balance | $ 59.84 | $ 559.52 | $ 1,658.88 | $ 2,962.56 | $ 2,962.56 | |
| Weighted Average Remaining Contractual Life (Years) | 2 years 2 months 8 days | 2 years 25 days | 4 years 9 months 18 days | 4 years 1 month 17 days | 4 years 9 months 14 days | 3 years 7 months 17 days |
| Number of Warrants, Issued | 2,919,036 | 48,616 | ||||
| Number of Warrants, Exercised | (470,307) | (143,188) | (14,209) | |||
| Number of Warrants, Cancelled | (3,598) | |||||
| Number of Warrants, Balance | 2,619,735 | 3,090,042 | 87,750 | 105,557 | 314,194 | 56,941 |
| Weighted Average Exercise Price, Balance | $ 67.15 | $ 59.84 | $ 1,963.20 | $ 1,658.88 | $ 559.52 | $ 2,962.56 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option outstanding weighted average remaining contractual terms. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|